Caribou Biosciences stockholders elect three directors and ratify auditor at 2024 annual meeting

Caribou Biosciences, Inc.

Elected Class III directors: Rachel Haurwitz (57.4M for), Dara Richardson-Heron (50.2M for), Natalie Sacks (50.2M for).
Ratified Deloitte & Touche as independent auditor for FY 2024 with 73.0M votes for, 0.2M against.
Broker non-votes of 13.6M shares on director elections; no broker votes on auditor ratification.
Annual meeting held June 13, 2024; all proposals passed as recommended by the board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.